Become a part of our global community, participate in surveys to improve healthcare and earn rewards.
We are an online survey platform created for healthcare professionals and patients to participate in paid online surveys, interviews, discussion forums, and other market research campaigns and to share their healthcare-related opinions and experiences. The information you provide improves healthcare products, services, treatments and overall healthcare. In your role as a panelist, you contribute to improving the healthcare industry one step at a time.
Get involved with a global community working to improve healthcare Through market research.
We are a global community of more than 1.2 million healthcare professionals, allied professionals, & patients who are shaping the future of healthcare. Our robust community shares opinions and experiences about healthcare through online surveys, interviews, and discussion forums. In addition to learning about future treatments, panelists update themselves about new developments in healthcare by participating in market research with MDForLives. The MDForLives team is a leader in compliance and information security, which ensures your privacy is protected at all times.
Once you successfully finish answering surveys, you will receive honoraria per survey and withdraw the rewards from global partners.
You are one of the driving forces behind the advancement of medical care and pharmaceuticals, and we reward you accordingly!
Become an MDForLives member and share your expert opinions through paid research.
For the time you invest in our surveys, members like you earn honoraria of up to $100 per survey.
As a result of your insights, the future of healthcare will be improved.
Are you a healthcare professional with something to say?
Tumor-agnostic treatments have come into prominence as a cutting-edge new method of treating cancer in an era where precision medicine has gained worldwide attention.
Colon cancer, rectal cancer, colorectal cancer, bowel cancer; the name changes depending on where the malignancy originates, but diagnosis, genetics, and management have become more uniform and standardized.
Dermatomyositis (DM) is a rare autoimmune disease that can occur at any age but is most common among people aged 40 to 60. The disease is also more common among women.